跳至主要内容
临床试验/NCT03598023
NCT03598023撤回不适用

A Randomized Clinical Investigation to Evaluate the Efficacy of Cytal® Burn Matrix in the Management of Partial-Thickness Burns to the Hand

Integra LifeSciences Corporation0 个研究点开始时间: 2018年8月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Time to Complete Wound Healing

研究概览

简要总结

This is a randomized controlled trial (RCT) aimed at determining if use of Cytal® Burn Matrix in the management of partial-thickness burns to the hand shows improved wound healing times when compared to EZ-Derm Porcine Xenograft.

详细描述

A single site, two arm, parallel-design randomized trial comparing Cytal® Burn Matrix to EZ-Derm® Porcine Xenograft, for patients with partial-thickness burns to the hand. Up to 60 patients from a single center will be recruited and randomized (using a 1:1 randomization scheme) to receive either Cytal® Burn Matrix or EZ-Derm®. Scar formation, number of wounds requiring autografting, wound infections, rate of healing, hand function and impact of treatment will be compared between study arms. Additionally, a cost analysis and review of individual and group changes in narcotic prescription patterns and employment status will be evaluated. The protocol defined patient follow-up is 6 months.

An independent biostatistician will review all participant data for power and futility analysis. In addition, a clinical events committee will adjudicate adverse events (AEs) and serious adverse events (SAEs)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and Female, 18 to 75 years of age.
  • Negative pregnancy test required.
  • Presence of partial thickness burns to one or both hands.
  • Thermal burn etiology.

排除标准

  • Allergy or hypersensitivity to materials in porcine-based study products or personal preference.
  • Friction, chemical, or electric burn etiology.
  • Immunosuppression.
  • Presence of a local and/or systemic infection.
  • Received prior treatment to the study site within 60 days of Screening.
  • Concurrent participation in another clinical trial.

结局指标

主要结局

Time to Complete Wound Healing

时间窗: 6 months

To Compare the time to complete wound healing between Groups 1 and 2

次要结局

  • Rate of Healing(6 months)
  • Evaluation of Scar Formation(6 months)
  • Wound Infections(21 days)
  • Compare treatment-emergent adverse event safety profile between Group 1 and Group 2(6 months)
  • Wounds Requiring Autografting(6 months)
  • Hand Function(6 months)
  • Impact of Treatment(6 months)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验